[Ph1 and C group marker in a acute leukemia associated with noramidopyrine treatment (author's transl)].
D000208:Acute Disease; D000983:Antipyrine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D002904:Chromosomes, Human, 21-22 and Y; D002906:Chromosomes, Human, 6-12 and X; D005334:Fever / Q000188:drug therapy; D006801:Humans; D007621:Karyotyping; D007938:Leukemia / Q000139:chemically induced; D007951:Leukemia, Myeloid / Q000209:etiology* / Q000235:genetics; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D007970:Leukopenia / Q000139:chemically induced*; D008297:Male; D008744:Methylamines / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000209:etiology
D008744:Methylamines; D000983:Antipyrine
Chromosome Philadelphie et marqueur du groupe C dans un cas de leucose aiguë découverte sous traitement par noramidopyrine